Package 50090-4364-0

Brand: invokana

Generic: canagliflozin
NDC Package

Package Facts

Identity

Package NDC 50090-4364-0
Digits Only 5009043640
Product NDC 50090-4364
Product ID 50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f
Description

90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0)

Marketing

Marketing Status
Marketed Since 2019-06-17
Brand invokana
Generic canagliflozin
Sample Package No

Linked Drug Pages (0)

No linked drugs yet.

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8f7706b7-8c1b-4c13-bb18-3ec25c98425f", "openfda": {"unii": ["0SAC974Z85"], "rxcui": ["1373471", "1373473"], "spl_set_id": ["9679460c-55f7-4826-b55c-fe116f020358"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0)", "package_ndc": "50090-4364-0", "marketing_start_date": "20190617"}], "brand_name": "INVOKANA", "product_id": "50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-4364", "generic_name": "canagliflozin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKANA", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "300 mg/1"}], "application_number": "NDA204042", "marketing_category": "NDA", "marketing_start_date": "20130329", "listing_expiration_date": "20261231"}